Search

Your search keyword '"PFÖHLER, Claudia"' showing total 654 results

Search Constraints

Start Over You searched for: Author "PFÖHLER, Claudia" Remove constraint Author: "PFÖHLER, Claudia"
654 results on '"PFÖHLER, Claudia"'

Search Results

52. Different phenotypes of drug‐induced anaphylaxis—Data from the European Anaphylaxis Registry

54. Reinduction of Hedgehog Inhibitors after Checkpoint Inhibition in Advanced Basal Cell Carcinoma: A Series of 12 Patients

59. Genomewide association study identifies GALC as susceptibility gene for mucous membrane pemphigoid

67. Different phenotypes of drug‐induced anaphylaxis—Data from the European Anaphylaxis Registry.

69. Genetic characterization of advanced conjunctival melanoma and response to systemic treatment

70. MAPKinase inhibition after failure of immune checkpoint blockade in patients with advanced melanoma – An evaluation of the multicenter prospective skin cancer registry ADOREG

71. Genetic Associations and Differential mRNA Expression Levels of Host Genes Suggest a Viral Trigger for Endemic Pemphigus Foliaceus

72. Clinical Models to Define Response and Survival With Anti–PD-1 Antibodies Alone or Combined With Ipilimumab in Metastatic Melanoma

73. Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany

75. Phenotype of drug-induced anaphylaxis depends on the eliciting drug - data from the European Anaphylaxis Registry

76. Effectiveness, Safety and Utilization of Vismodegib for Locally Advanced Basal Cell Carcinoma Under Real-world Conditions: Non-interventional Cohort Study JONAS

77. Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity

78. TERT promoter mutations are associated with longer progression-free and overall survival in patients with BRAF-mutant melanoma receiving BRAF and MEK inhibitor therapy

79. Characterization and Outcome of RAC1 Mutated Melanoma

80. Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition — A Descriptive Observational Retrospective Multicenter Analysis

88. NF1-mutated melanomas reveal distinct clinical characteristics depending on tumour origin and respond favourably to immune checkpoint inhibitors

89. Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition — A Descriptive Observational Retrospective Multicenter Analysis

90. Contact dermatitis and sensitization in professional musicians

93. Polymorphisms in the mitochondrially encoded ATP synthase 8 gene are associated with susceptibility to bullous pemphigoid in the German population

96. Digital Quantification of Tumor PD-L1 Predicts Outcome of PD-1-Based Immune Checkpoint Therapy in Metastatic Melanoma

97. Genetic association and differential expression of HLA Complex Group lncRNAs in pemphigus

100. Clinical characteristics and therapy response in unresectable melanoma patients stage IIIB-IIID with in-transit and satellite metastases

Catalog

Books, media, physical & digital resources